Depacon Side Effects
|
|
Did You Have a Depacon Side Effect? How Effective is Depacon for You? |
Gait Disturbance, Diarrhoea, Overdose, Unresponsive To Stimuli, Back Pain, Tinnitus, Dysphagia, Rhinorrhoea, Pyrexia (7271590-9)
on Jan 21, 2011 Female patient from UNITED STATES , 33 years of age, weighting 105.0 lb, was diagnosed with
Dizziness, Diplopia (7206870-6)
Patient was taking Depacon (View Usage). Patient had the following side effects: dizziness (dizziness Questions), diplopia on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 130.1 lb, was diagnosed with
Patient was taking other medications:
Hepatic Enzyme Increased, Status Epilepticus (6917820-1)
Adverse event was reported on Aug 06, 2010 by a Male patient taking Depacon (View Usage) (Dosage: 12mg/kg For 1 Hour Infusion (480mg/hour)) was diagnosed with
Hepatic Enzyme Increased, Status Epilepticus (6888822-9)
on Jul 22, 2010 Male patient from PHILIPPINES , child 6 years of age, weighting 88.18 lb, was diagnosed with
Overdose (6762661-1)
on Jun 01, 2010 Female patient from PHILIPPINES , weighting 12.13 lb, was diagnosed with
Activities Of Daily Living Impaired, Apallic Syndrome, Gait Disturbance (6410725-4)
Patient was taking Depacon (View Usage). After Depacon was administered, patient had the following side effects: activities of daily living impaired, apallic syndrome, gait disturbance on Oct 12, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 190.2 lb, was diagnosed with
Patient was taking other medications:
Acidosis (6387009-6)
Adverse event was reported on Sep 25, 2009 by a Male patient taking Depacon (View Usage) (Dosage: Bolus: 15mg/kg/163 Mg/100) was diagnosed with
Acidosis, Haemodynamic Instability, Procedural Complication, Ventricular Fibrillation (6369159-3)
on Sep 18, 2009 Male patient from UNITED STATES , 32 years of age, weighting 240.3 lb, was treated with Depacon (View Usage). Patient had the following side effects: acidosis, haemodynamic instability, procedural complication, ventricular fibrillation. Depacon dosage: Bolus:15mg/kg,1635 Mg/100.
Acidosis (6360406-0)
on Sep 11, 2009 Male patient from UNITED STATES , 32 years of age, weighting 240.3 lb, was diagnosed with
Acidosis, Blood Pressure Abnormal, Haemodynamic Instability, Ventricular Fibrillation (6356898-3)
Patient was taking Depacon (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, blood pressure abnormal, haemodynamic instability, ventricular fibrillation on Sep 10, 2009 from UNITED STATES Additional patient health information: Male patient , 32 years of age, weighting 240.3 lb, . Depacon dosage: Bolus: 15mg/kg. 1635mg/100.
Acidosis (6349787-1)
Adverse event was reported on Sep 04, 2009 by a Male patient taking Depacon (View Usage) (Dosage: Bolus: 15mg/kg/163 Mg/100) was diagnosed with
Ammonia Increased, Coma, Grand Mal Convulsion, Metabolic Acidosis, Renal Impairment (6049138-6)
on Apr 02, 2008 Female patient from UNITED STATES , 42 years of age, was diagnosed with
Liver Function Test Abnormal (6049129-5)
on Jan 15, 2008 Male patient from UNITED STATES , 17 years of age, was treated with Depacon(View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal. Depacon dosage: N/A.
Amnesia, Cold Sweat, Gait Disturbance, Migraine, Pain (5677592-8)
Patient was taking Depacon (View Usage). Patient had the following side effects: amnesia, cold sweat, gait disturbance, migraine (migraine Questions), pain (pain Questions) on Jun 20, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 160.1 lb, was diagnosed with
Patient was taking other medications:
Encephalopathy (5489581-7)
Adverse event was reported on Oct 16, 2007 by a Female patient taking Depacon (View Usage) (Dosage: 2 - 6 Mg/kg/hour Iv Drip) was diagnosed with
Blister, Erythema, Musculoskeletal Pain, Oedema Peripheral, Rash (5408862-6)
on Aug 03, 2007 Male patient from FRANCE , 48 years of age, was diagnosed with
Patient was taking other medications:
Aggression, Mania, Mental Disorder, Oedema Peripheral, Toxic Epidermal Necrolysis, Urticaria (5342043-X)
on May 30, 2007 Male patient from UNITED STATES , 57 years of age, weighting 250.0 lb, was diagnosed with
Agitation, Hallucination, Rash (5313275-1)
Patient was taking Depacon (View Usage). After Depacon was administered, patient had the following side effects: agitation, hallucination, rash (rash Questions) on Jan 23, 2006 from UNITED STATES Additional patient health information: Male patient , 18 years of age, was diagnosed with
Patient was taking other medications:
Blister, Erythema, Musculoskeletal Pain, Oedema Peripheral, Rash (5112558-8)
Adverse event was reported on Sep 11, 2006 by a Male patient taking Depacon (View Usage) (Dosage: N/A) was diagnosed with
Patient was taking other medications:
Ammonia Increased, Depressed Level Of Consciousness (5011248-X)
on May 23, 2006 Female patient from UNITED STATES , 15 years of age, was diagnosed with
Pancreatitis Haemorrhagic (4960920-6)
on Dec 14, 2004 Female patient from UNITED STATES , 47 years of age, was diagnosed with
Encephalopathy, Leukodystrophy, Motor Dysfunction, Mutism, Staphylococcal Bacteraemia, Unevaluable Event (4882468-X)
Patient was taking Depacon (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy, leukodystrophy, motor dysfunction, mutism, staphylococcal bacteraemia, unevaluable event on Nov 24, 2003 from FRANCE Additional patient health information: Female patient , 79 years of age, . Depacon dosage: N/A. Patient was hospitalized.
Encephalopathy, Leukodystrophy, Motor Dysfunction, Mutism, Staphylococcal Bacteraemia, Unevaluable Event (4882386-7)
Adverse event was reported on Nov 24, 2003 by a Female patient taking Depacon (View Usage) (Dosage: N/A) . Location: FRANCE , 79 years of age, Patient had the following side effects: encephalopathy, leukodystrophy, motor dysfunction, mutism, staphylococcal bacteraemia, unevaluable event. Patient was hospitalized.
Cerebrovascular Arteriovenous Malformation, Pancytopenia (4704089-1)
on Jun 02, 2005 Female patient from , 21 years of age, was diagnosed with
Patient was taking other medications:
Pancreatitis Haemorrhagic (4559770-4)
on Sep 21, 2004 Female patient from , 47 years of age, was diagnosed with
on Jan 21, 2011 Female patient from UNITED STATES , 33 years of age, weighting 105.0 lb, was diagnosed with
- complicated migraine
Dizziness, Diplopia (7206870-6)
Patient was taking Depacon (View Usage). Patient had the following side effects: dizziness (dizziness Questions), diplopia on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 130.1 lb, was diagnosed with
- convulsion
Patient was taking other medications:
- TOPAMAX (View Topamax Review and Topamax Label )
- LAMICTAL (View Lamictal Review and Lamictal Label )
- DEPAKOTE ER (View Depakote Er Review and Depakote Er Label )
Hepatic Enzyme Increased, Status Epilepticus (6917820-1)
Adverse event was reported on Aug 06, 2010 by a Male patient taking Depacon (View Usage) (Dosage: 12mg/kg For 1 Hour Infusion (480mg/hour)) was diagnosed with
- convulsion
Hepatic Enzyme Increased, Status Epilepticus (6888822-9)
on Jul 22, 2010 Male patient from PHILIPPINES , child 6 years of age, weighting 88.18 lb, was diagnosed with
- febrile convulsion
Overdose (6762661-1)
on Jun 01, 2010 Female patient from PHILIPPINES , weighting 12.13 lb, was diagnosed with
- convulsion
Activities Of Daily Living Impaired, Apallic Syndrome, Gait Disturbance (6410725-4)
Patient was taking Depacon (View Usage). After Depacon was administered, patient had the following side effects: activities of daily living impaired, apallic syndrome, gait disturbance on Oct 12, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 190.2 lb, was diagnosed with
- convulsion
Patient was taking other medications:
Acidosis (6387009-6)
Adverse event was reported on Sep 25, 2009 by a Male patient taking Depacon (View Usage) (Dosage: Bolus: 15mg/kg/163 Mg/100) was diagnosed with
- prophylaxis
- nervous system disorder
Acidosis, Haemodynamic Instability, Procedural Complication, Ventricular Fibrillation (6369159-3)
on Sep 18, 2009 Male patient from UNITED STATES , 32 years of age, weighting 240.3 lb, was treated with Depacon (View Usage). Patient had the following side effects: acidosis, haemodynamic instability, procedural complication, ventricular fibrillation. Depacon dosage: Bolus:15mg/kg,1635 Mg/100.
Acidosis (6360406-0)
on Sep 11, 2009 Male patient from UNITED STATES , 32 years of age, weighting 240.3 lb, was diagnosed with
- prophylaxis
- nervous system disorder
Acidosis, Blood Pressure Abnormal, Haemodynamic Instability, Ventricular Fibrillation (6356898-3)
Patient was taking Depacon (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, blood pressure abnormal, haemodynamic instability, ventricular fibrillation on Sep 10, 2009 from UNITED STATES Additional patient health information: Male patient , 32 years of age, weighting 240.3 lb, . Depacon dosage: Bolus: 15mg/kg. 1635mg/100.
Acidosis (6349787-1)
Adverse event was reported on Sep 04, 2009 by a Male patient taking Depacon (View Usage) (Dosage: Bolus: 15mg/kg/163 Mg/100) was diagnosed with
- prophylaxis
- nervous system disorder
Ammonia Increased, Coma, Grand Mal Convulsion, Metabolic Acidosis, Renal Impairment (6049138-6)
on Apr 02, 2008 Female patient from UNITED STATES , 42 years of age, was diagnosed with
- convulsion
Liver Function Test Abnormal (6049129-5)
on Jan 15, 2008 Male patient from UNITED STATES , 17 years of age, was treated with Depacon(View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal. Depacon dosage: N/A.
Amnesia, Cold Sweat, Gait Disturbance, Migraine, Pain (5677592-8)
Patient was taking Depacon (View Usage). Patient had the following side effects: amnesia, cold sweat, gait disturbance, migraine (migraine Questions), pain (pain Questions) on Jun 20, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 160.1 lb, was diagnosed with
- migraine (migraine Questions)
- thrombosis prophylaxis
- headache (headache Questions)
- blood pressure (blood pressure Questions)
Patient was taking other medications:
- ASPIRIN (View Aspirin Review and Aspirin Label )
- PARACETAMOL (View Paracetamol Review and Paracetamol Label )
- PROPRANOLOL (View Propranolol Review and Propranolol Label )
- METAXALONE (View Metaxalone Review and Metaxalone Label )
Encephalopathy (5489581-7)
Adverse event was reported on Oct 16, 2007 by a Female patient taking Depacon (View Usage) (Dosage: 2 - 6 Mg/kg/hour Iv Drip) was diagnosed with
- convulsion
Blister, Erythema, Musculoskeletal Pain, Oedema Peripheral, Rash (5408862-6)
on Aug 03, 2007 Male patient from FRANCE , 48 years of age, was diagnosed with
- epilepsy (epilepsy Questions)
Patient was taking other medications:
- HEPARIN FRACTION, SODIUM SALT (View Heparin-fraction, Sodium Salt Review and Heparin-fraction, Sodium Salt Label )
Aggression, Mania, Mental Disorder, Oedema Peripheral, Toxic Epidermal Necrolysis, Urticaria (5342043-X)
on May 30, 2007 Male patient from UNITED STATES , 57 years of age, weighting 250.0 lb, was diagnosed with
- mania
- psychotic disorder (psychotic disorder Questions)
Agitation, Hallucination, Rash (5313275-1)
Patient was taking Depacon (View Usage). After Depacon was administered, patient had the following side effects: agitation, hallucination, rash (rash Questions) on Jan 23, 2006 from UNITED STATES Additional patient health information: Male patient , 18 years of age, was diagnosed with
- convulsion
Patient was taking other medications:
Blister, Erythema, Musculoskeletal Pain, Oedema Peripheral, Rash (5112558-8)
Adverse event was reported on Sep 11, 2006 by a Male patient taking Depacon (View Usage) (Dosage: N/A) was diagnosed with
- epilepsy (epilepsy Questions)
Patient was taking other medications:
- HEPARIN FRACTION, SODIUM SALT (View Heparin-fraction, Sodium Salt Review and Heparin-fraction, Sodium Salt Label )
Ammonia Increased, Depressed Level Of Consciousness (5011248-X)
on May 23, 2006 Female patient from UNITED STATES , 15 years of age, was diagnosed with
- epilepsy (epilepsy Questions)
Pancreatitis Haemorrhagic (4960920-6)
on Dec 14, 2004 Female patient from UNITED STATES , 47 years of age, was diagnosed with
- status epilepticus
- subdural haematoma
Encephalopathy, Leukodystrophy, Motor Dysfunction, Mutism, Staphylococcal Bacteraemia, Unevaluable Event (4882468-X)
Patient was taking Depacon (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy, leukodystrophy, motor dysfunction, mutism, staphylococcal bacteraemia, unevaluable event on Nov 24, 2003 from FRANCE Additional patient health information: Female patient , 79 years of age, . Depacon dosage: N/A. Patient was hospitalized.
Encephalopathy, Leukodystrophy, Motor Dysfunction, Mutism, Staphylococcal Bacteraemia, Unevaluable Event (4882386-7)
Adverse event was reported on Nov 24, 2003 by a Female patient taking Depacon (View Usage) (Dosage: N/A) . Location: FRANCE , 79 years of age, Patient had the following side effects: encephalopathy, leukodystrophy, motor dysfunction, mutism, staphylococcal bacteraemia, unevaluable event. Patient was hospitalized.
Cerebrovascular Arteriovenous Malformation, Pancytopenia (4704089-1)
on Jun 02, 2005 Female patient from , 21 years of age, was diagnosed with
- convulsion prophylaxis
Patient was taking other medications:
- CLORAZEPATE DIPOTASSIUM (10.0 Mg (10.0 Mg, 1 In 1 D) Oral) (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label )
- METAMIZOLE MAGNESIUM (2.0 Mg, 3 In 1 D Intravenous) (View Metamizole Magnesium Review and Metamizole Magnesium Label )
- OMEPRAZOLE (40.0 Mg (40.0 Mg, 1 In 1 D)) (View Omeprazole Review and Omeprazole Label )
- ACETAMINOPHEN (4.0 Gm, 4 In 1 D Intravenous) (View Acetaminophen Review and Acetaminophen Label )
- KETOROLAC TROMETHAMINE (90.0 Mg, 3 In 1 D Intravenous) (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label )
- BUPRENORPHINE HCL (View Buprenorphine Hcl Review and Buprenorphine Hcl Label )
- ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label )
Pancreatitis Haemorrhagic (4559770-4)
on Sep 21, 2004 Female patient from , 47 years of age, was diagnosed with
- status epilepticus
Depacon Forum
Depacon Adverse Effect Reports (FDA)
Depacon InformationAlternative DEPACON Names:VALPROATE Substance:VALPROATE Depacon Dosage, Warnings, Usage. Side Effects reported to FDA: 25. View FDA Adverse Reports Depacon safety alerts: 2002 2000 Reported deaths: 2 Reported hospitalizations: 11 |